Ballast Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$542K Hold
452
0.13% 79
2026
Q1
$416K Sell
452
-2
-0.4% -$2.03K 0.12% 77
2025
Q4
$488K Sell
454
-20
-4% -$19.1K 0.13% 72
2025
Q3
$362K Buy
474
+22
+5% +$16.4K 0.1% 81
2025
Q2
$352K Sell
452
-2
-0.4% -$1.55K 0.1% 81
2025
Q1
$375K Hold
454
0.12% 81
2024
Q4
$350K Buy
454
+2
+0.4% +$1.66K 0.11% 82
2024
Q3
$400K Hold
452
0.12% 82
2024
Q2
$409K Sell
452
-1
-0.2% -$800 0.13% 82
2024
Q1
$352K Buy
453
+1
+0.2% +$712 0.12% 88
2023
Q4
$263K Sell
452
-133
-23% -$77.6K 0.1% 95
2023
Q3
$314K Hold
585
0.13% 90
2023
Q2
$274K Sell
585
-200
-25% -$83.9K 0.1% 96
2023
Q1
$270K Hold
785
0.11% 93
2022
Q4
$287K Sell
785
-120
-13% -$42.5K 0.13% 87
2022
Q3
$293K Sell
905
-15
-2% -$4.75K 0.14% 82
2022
Q2
$298K Hold
920
0.13% 83
2022
Q1
$263K Hold
920
0.1% 100
2021
Q4
$254K Buy
+920
New +$233K 0.1% 98

Other funds holding LLY

Ballast Advisors's LLY Position: Q2 2026 in Review

Ballast Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 452 shares worth $542K. The position accounts for 0.13% of the portfolio, ranked #79.

Ballast Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ballast Advisors held 452 shares of Eli Lilly worth $542K as of Q2 2026.
  • Ballast Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.13% of Ballast Advisors's portfolio in Q2 2026, its #79 holding.
  • Ballast Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ballast Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.